首页|慢传输型便秘采用卯时饮水联合便秘舒通仪治疗的临床效果观察

慢传输型便秘采用卯时饮水联合便秘舒通仪治疗的临床效果观察

扫码查看
目的 观察慢传输型便秘(STC)患者采用卯时饮水联合便秘舒通仪治疗的临床疗效.方法 研究对象为符合诊断标准的 100 例慢传输型便秘患者,采用随机数字表法分为对照组和观察组,每组 50 例.对照组患者给予口服枸橼酸莫沙必利片治疗,观察组患者给予卯时饮水联合便秘舒通仪治疗.对比两组患者每周自发完全排便次数(SCBM)、便秘患者症状自评量表(PAC-SYM)评分、Bristol粪便性状量表(BSFS)评分、治疗效果.结果 治疗前,两组患者的腹部症状、直肠症状、粪便性状评分对比无明显差异(P>0.05);治疗后,观察组患者腹部症状、直肠症状、粪便性状评分分别为(1.39±0.28)、(1.01±0.76)、(0.51±0.44)分,均低于对照组的(2.87±0.37)、(1.73±0.82)、(1.23±0.66)分(P<0.05).治疗后,观察组患者SCBM(4.02±0.35)次/周多于对照组的(2.77±0.29)次/周,BSFS评分(5.22±0.41)分高于对照组的(3.37±0.34)分(P<0.05).治疗后,观察组患者总有效率 100.00%高于对照组的 86.00%(P<0.05).结论 慢传输型便秘采用卯时饮水联合便秘舒通仪治疗获得了较佳的临床效果,明显改善便秘症状,临床应用价值显著.
Observations on the clinical effect of slow transit constipation treated by drinking water at Moushi combined with constipation relief device
Objective To observe the clinical efficacy of slow transit constipation(STC)treated by drinking water at Moushi combined with constipation relief device.Methods 100 patients with slow transit constipation who met the diagnostic criteria as study subjects were divided into a control group and an observation group by random number table method,with 50 cases in each group.The control group was treated with oral mosapride citrate tablets,and the observation group was treated with drinking water at Moushi combined with constipation relief device.The spontaneous complete bowel movement(SCBM),the score of patient assessment of constipation symptoms(PAC-SYM),the score of Bristol stool form scale(BSFS)and the therapeutic effect of the two groups were compared.Results Before treatment,there were no significant differences in scores of abdominal symptoms,rectal symptoms and fecal traits between the two groups(P>0.05).After treatment,the scores of abdominal symptoms,rectal symptoms and fecal traits were(1.39±0.28),(1.01±0.76)and(0.51±0.44)points in the observation group,which were lower than(2.87±0.37),(1.73±0.82)and(1.23±0.66)points in the control group(P<0.05).After treatment,SCBM of(4.02±0.35)times/week in the observation group was more than(2.77±0.29)times/week in the control group,and BSFS score of(5.22±0.41)points was higher than(3.37±0.34)points in the control group(P<0.05).After treatment,the total effective rate of 100.00%in the observation group was higher than 86.00%in the control group(P<0.05).Conclusion The treatment of slow transit constipation by means of drinking water at Moushi combined with constipation relief device has obtained better clinical effect.It can significantly improve the constipation symptoms,and the value of clinical application is remarkable.

Slow transit constipationConstipation relief deviceDrinking water at MoushiMosapride citrate tabletsClinical study

徐洪侠、李婷珊、陈惠冰、张春梅、郑少康

展开 >

528600 广东省中山市中医院肛肠科

慢传输型便秘 便秘舒通仪 卯时饮水 枸橼酸莫沙必利片 临床研究

2024

中国实用医药
中国康复医学会

中国实用医药

影响因子:0.797
ISSN:1673-7555
年,卷(期):2024.19(19)